RNU6-63P

Across TCGA pan-cancer cohorts, RNU6-63P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RNU6-63P’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where RNU6-63P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-63P is over-expressed in tumor.

LIHC are the cancer types where RNU6-63P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-63P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.049	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

RNU6-63P–LIHC

Open the LIHC breakdown →